New DarioHealth Study Shows Increased Digital Therapeutics Engagement Leads to Marked Reduction in Blood Glucose, Lower High Readings among Type 2 Diabetic Seniors

Stock Information for DarioHealth Corp.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About DarioHealth Corp.

Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution
Dario Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health
Two National Employers Select Dario's Integrated Chronic Condition Solution to Improve Employee Health
DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating Results
DARIOHEALTH TO REPORT FOURTH QUARTER 2023 RESULTS ON THURSDAY, MARCH 28TH
New Research from Dario Demonstrates Ability to Deliver Improved Health Outcomes with Integrated Solution for Members Managing Weight and Blood Glucose with or without GLP-1 Medications
DARIOHEALTH TO PARTICIPATE IN THE COWEN 43RD ANNUAL HEALTHCARE CONFERENCE
Today's Schedule at The MicroCap Rodeo Winter Wrap Up Conference

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.